85 related articles for article (PubMed ID: 3349475)
1. Down modulation of fibronectin messenger RNA in metastasizing rat prostatic cancer cells revealed by differential hybridization analysis.
Schalken JA; Ebeling SB; Isaacs JT; Treiger B; Bussemakers MJ; de Jong ME; Van de Ven WJ
Cancer Res; 1988 Apr; 48(8):2042-6. PubMed ID: 3349475
[TBL] [Abstract][Full Text] [Related]
2. Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis.
Bussemakers MJ; van de Ven WJ; Debruyne FM; Schalken JA
Cancer Res; 1991 Jan; 51(2):606-11. PubMed ID: 1702360
[TBL] [Abstract][Full Text] [Related]
3. Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model.
Mohler JL; Levy F; Sharief Y
Cancer Res; 1991 Dec; 51(24):6580-5. PubMed ID: 1742730
[TBL] [Abstract][Full Text] [Related]
4. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
Oates AJ; Barraclough R; Rudland PS
Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
[TBL] [Abstract][Full Text] [Related]
5. Transfected neu oncogene induces human prostate cancer metastasis.
Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.
Powell CT; Gschwend JE; Fair WR; Brittis NJ; Stec D; Huryk R
Cancer Res; 1996 Sep; 56(18):4137-41. PubMed ID: 8797581
[TBL] [Abstract][Full Text] [Related]
7. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
8. Application of an improved cDNA competition technique to identify prostate cancer-associated gene.
Rinaldy AR; Steiner MS
DNA Cell Biol; 1999 Nov; 18(11):829-36. PubMed ID: 10595396
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning of a unique complementary DNA of rat myosin regulatory light chain and its elevated expression in v-src-transformed rat culture cell lines.
Ozaki T; Asai T; Sakiyama S
Cell Growth Differ; 1993 Nov; 4(11):939-45. PubMed ID: 8297799
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors.
Powell CT; Fair WR; Heston WD
Cell Growth Differ; 1994 Feb; 5(2):143-9. PubMed ID: 8180127
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional down-regulation of a rat gene, WDNM2, in metastatic DMBA-8 cells.
Dear TN; McDonald DA; Kefford RF
Cancer Res; 1989 Oct; 49(19):5323-8. PubMed ID: 2504488
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of complementary DNA clones for genes overexpressed in chemically induced rat hepatomas.
Corral M; Defer N; Paris B; Raymondjean M; Corcos D; Tichonicky L; Kruh J; Glaise D; Kneip B; Guguen-Guillouzo C
Cancer Res; 1986 Oct; 46(10):5119-24. PubMed ID: 2428472
[TBL] [Abstract][Full Text] [Related]
13. Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublines.
Tieva A; Bergh A; Damber JE
Acta Oncol; 2005; 44(3):299-303. PubMed ID: 16076703
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF.
Gretzer MB; Chan DW; van Rootselaar CL; Rosenzweig JM; Dalrymple S; Mangold LA; Partin AW; Veltri RW
Prostate; 2004 Sep; 60(4):325-31. PubMed ID: 15264244
[TBL] [Abstract][Full Text] [Related]
15. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
Reyes I; Tiwari R; Geliebter J; Reyes N
Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
[TBL] [Abstract][Full Text] [Related]
16. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
17. Reduced lysyl oxidase messenger RNA levels in experimental and human prostate cancer.
Ren C; Yang G; Timme TL; Wheeler TM; Thompson TC
Cancer Res; 1998 Mar; 58(6):1285-90. PubMed ID: 9515817
[TBL] [Abstract][Full Text] [Related]
18. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13.
Gao AC; Lou W; Dong JT; Isaacs JT
Cancer Res; 1997 Mar; 57(5):846-9. PubMed ID: 9041184
[TBL] [Abstract][Full Text] [Related]
19. Genetic factors and metastatic potential of prostatic cancer.
Ichikawa T; Ichikawa Y; Isaacs JT
Cancer Surv; 1991; 11():35-42. PubMed ID: 1841756
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential.
Urtreger AJ; Werbajh SE; Verrecchia F; Mauviel A; Puricelli LI; Kornblihtt AR; Bal de Kier Joffé ED
Oncol Rep; 2006 Dec; 16(6):1403-10. PubMed ID: 17089068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
